FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and deals with hard pharmaceutical composition, which includes escitalopram or its pharmaceutically acceptable salt and/or solvate.
EFFECT: invention ensures absence of disadvantages as to fluidity and technical characteristics.
12 cl, 8 ex, 1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOSITION | 2006 |
|
RU2821230C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
| SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD FOR MAKING THEM | 2007 |
|
RU2449786C2 |
| GALENA COMPOSITION OF ALISKIREN AND HYDROCHLOROTHIAZIDE | 2007 |
|
RU2491058C2 |
| HALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2005 |
|
RU2384328C2 |
| GALENIC FORMULATIONS OF ALISKIREN | 2008 |
|
RU2483718C2 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING NILOTINIB OR ITS SALTS | 2007 |
|
RU2469707C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | 2016 |
|
RU2736941C2 |
